Posted On: 01/15/2016 7:53:10 PM
Post# of 30066
Exactly, the need and market for such a treatment are huge. What may work for some, may not work for everyone, just look at the different antibiotics that we have.
I actually think the RGIN deal is a solid deal for us. If we can make it threw this short term disaster and find solid partners and non dilutive funding that can take one of our current products to market and produce revenue. Setting up acquisitions like this in the future makes sense.
The key for us still comes down to execution. If we can survive the next year and a half then the sky is the limit but with current tendencies of toxic financing, and CEO overhype this company may not make it that long.
Its a penny stock on the OTC so the risk of bankruptcy has always been there. All we can do now is sit back and wait.
I actually think the RGIN deal is a solid deal for us. If we can make it threw this short term disaster and find solid partners and non dilutive funding that can take one of our current products to market and produce revenue. Setting up acquisitions like this in the future makes sense.
The key for us still comes down to execution. If we can survive the next year and a half then the sky is the limit but with current tendencies of toxic financing, and CEO overhype this company may not make it that long.
Its a penny stock on the OTC so the risk of bankruptcy has always been there. All we can do now is sit back and wait.
(0)
(0)
